Logo image of ARCAD.AS

ARCADIS NV (ARCAD.AS) Stock Fundamental Analysis

AMS:ARCAD - Euronext Amsterdam - NL0006237562 - Common Stock - Currency: EUR

41.02  -0.12 (-0.29%)

Fundamental Rating

4

ARCAD gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 32 industry peers in the Professional Services industry. ARCAD scores excellent on profitability, but there are some minor concerns on its financial health. ARCAD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

ARCAD had positive earnings in the past year.
ARCAD had a positive operating cash flow in the past year.
In the past 5 years ARCAD has always been profitable.
In the past 5 years ARCAD always reported a positive cash flow from operatings.
ARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

ARCAD has a Return On Assets of 6.22%. This is in the better half of the industry: ARCAD outperforms 65.63% of its industry peers.
ARCAD has a better Return On Equity (19.71%) than 71.88% of its industry peers.
ARCAD has a Return On Invested Capital of 11.91%. This is in the better half of the industry: ARCAD outperforms 62.50% of its industry peers.
ARCAD had an Average Return On Invested Capital over the past 3 years of 9.74%. This is in line with the industry average of 10.46%.
The 3 year average ROIC (9.74%) for ARCAD is below the current ROIC(11.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.22%
ROE 19.71%
ROIC 11.91%
ROA(3y)4.63%
ROA(5y)4.14%
ROE(3y)15.99%
ROE(5y)13.31%
ROIC(3y)9.74%
ROIC(5y)9.75%
ARCAD.AS Yearly ROA, ROE, ROICARCAD.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

ARCAD has a Profit Margin of 6.26%. This is in the better half of the industry: ARCAD outperforms 71.88% of its industry peers.
In the last couple of years the Profit Margin of ARCAD has grown nicely.
With a decent Operating Margin value of 10.03%, ARCAD is doing good in the industry, outperforming 65.63% of the companies in the same industry.
ARCAD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.03%
PM (TTM) 6.26%
GM N/A
OM growth 3Y5.13%
OM growth 5Y8.46%
PM growth 3Y-1.46%
PM growth 5Y67.33%
GM growth 3YN/A
GM growth 5YN/A
ARCAD.AS Yearly Profit, Operating, Gross MarginsARCAD.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

More info and screens

5

2. Health

2.1 Basic Checks

ARCAD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ARCAD has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ARCAD has more shares outstanding
The debt/assets ratio for ARCAD has been reduced compared to a year ago.
ARCAD.AS Yearly Shares OutstandingARCAD.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ARCAD.AS Yearly Total Debt VS Total AssetsARCAD.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

ARCAD has an Altman-Z score of 2.60. This is not the best score and indicates that ARCAD is in the grey zone with still only limited risk for bankruptcy at the moment.
ARCAD has a Altman-Z score of 2.60. This is comparable to the rest of the industry: ARCAD outperforms 43.75% of its industry peers.
ARCAD has a debt to FCF ratio of 3.66. This is a good value and a sign of high solvency as ARCAD would need 3.66 years to pay back of all of its debts.
ARCAD has a Debt to FCF ratio (3.66) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.78 indicates that ARCAD is somewhat dependend on debt financing.
ARCAD's Debt to Equity ratio of 0.78 is in line compared to the rest of the industry. ARCAD outperforms 46.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 3.66
Altman-Z 2.6
ROIC/WACC1.84
WACC6.46%
ARCAD.AS Yearly LT Debt VS Equity VS FCFARCAD.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

ARCAD has a Current Ratio of 1.22. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
ARCAD has a better Current ratio (1.22) than 62.50% of its industry peers.
ARCAD has a Quick Ratio of 1.22. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ARCAD (1.22) is better than 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
ARCAD.AS Yearly Current Assets VS Current LiabilitesARCAD.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.36% over the past year.
The Revenue has been growing slightly by 0.76% in the past year.
EPS 1Y (TTM)3.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)0.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.41%

3.2 Future

Based on estimates for the next years, ARCAD will show a decrease in Earnings Per Share. The EPS will decrease by -5.28% on average per year.
ARCAD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.52% yearly.
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%

3.3 Evolution

ARCAD.AS Yearly Revenue VS EstimatesARCAD.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
ARCAD.AS Yearly EPS VS EstimatesARCAD.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.64 indicates a quite expensive valuation of ARCAD.
ARCAD's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.45, ARCAD is valued at the same level.
With a Price/Forward Earnings ratio of 23.87, ARCAD is valued on the expensive side.
ARCAD's Price/Forward Earnings is on the same level as the industry average.
ARCAD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.64
Fwd PE 23.87
ARCAD.AS Price Earnings VS Forward Price EarningsARCAD.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

68.75% of the companies in the same industry are more expensive than ARCAD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ARCAD is valued a bit cheaper than 68.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.16
EV/EBITDA 8.31
ARCAD.AS Per share dataARCAD.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ARCAD has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as ARCAD's earnings are expected to decrease with -7.26% in the coming years.
PEG (NY)2.74
PEG (5Y)N/A
EPS Next 2Y5.64%
EPS Next 3Y-7.26%

More info and screens

5

5. Dividend

5.1 Amount

ARCAD has a Yearly Dividend Yield of 2.43%.
Compared to an average industry Dividend Yield of 2.76, ARCAD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, ARCAD has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.43%

5.2 History

On average, the dividend of ARCAD grows each year by 31.53%, which is quite nice.
Dividend Growth(5Y)31.53%
Div Incr Years6
Div Non Decr Years6
ARCAD.AS Yearly Dividends per shareARCAD.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

31.28% of the earnings are spent on dividend by ARCAD. This is a low number and sustainable payout ratio.
DP31.28%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
ARCAD.AS Yearly Income VS Free CF VS DividendARCAD.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
ARCAD.AS Dividend Payout.ARCAD.AS Dividend Payout, showing the Payout Ratio.ARCAD.AS Dividend Payout.PayoutRetained Earnings

More info and screens

ARCADIS NV

AMS:ARCAD (7/4/2025, 7:00:00 PM)

41.02

-0.12 (-0.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)05-07 2025-05-07
Earnings (Next)07-31 2025-07-31
Inst Owners50.15%
Inst Owner ChangeN/A
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap3.71B
Analysts81.11
Price Target63.86 (55.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.43%
Yearly Dividend0.85
Dividend Growth(5Y)31.53%
DP31.28%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.43%
Min Revenue beat(2)-4.47%
Max Revenue beat(2)-4.39%
Revenue beat(4)0
Avg Revenue beat(4)-11.32%
Min Revenue beat(4)-30.71%
Max Revenue beat(4)-4.39%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.93%
PT rev (3m)-12.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.57%
Valuation
Industry RankSector Rank
PE 26.64
Fwd PE 23.87
P/S 0.96
P/FCF 12.16
P/OCF 10.6
P/B 3.01
P/tB N/A
EV/EBITDA 8.31
EPS(TTM)1.54
EY3.75%
EPS(NY)1.72
Fwd EY4.19%
FCF(TTM)3.37
FCFY8.22%
OCF(TTM)3.87
OCFY9.43%
SpS42.9
BVpS13.63
TBVpS-3.02
PEG (NY)2.74
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.22%
ROE 19.71%
ROCE 16.66%
ROIC 11.91%
ROICexc 14.06%
ROICexgc 58.82%
OM 10.03%
PM (TTM) 6.26%
GM N/A
FCFM 7.86%
ROA(3y)4.63%
ROA(5y)4.14%
ROE(3y)15.99%
ROE(5y)13.31%
ROIC(3y)9.74%
ROIC(5y)9.75%
ROICexc(3y)11.24%
ROICexc(5y)11.87%
ROICexgc(3y)46.91%
ROICexgc(5y)45.96%
ROCE(3y)13.66%
ROCE(5y)13.67%
ROICexcg growth 3Y8.93%
ROICexcg growth 5Y-10.74%
ROICexc growth 3Y2.55%
ROICexc growth 5Y6.48%
OM growth 3Y5.13%
OM growth 5Y8.46%
PM growth 3Y-1.46%
PM growth 5Y67.33%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 3.66
Debt/EBITDA 1.82
Cap/Depr 32.14%
Cap/Sales 1.16%
Interest Coverage 7.48
Cash Conversion 66.16%
Profit Quality 125.51%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 2.6
F-Score8
WACC6.46%
ROIC/WACC1.84
Cap/Depr(3y)29.56%
Cap/Depr(5y)27.6%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.19%
Profit Quality(3y)159.52%
Profit Quality(5y)558.67%
High Growth Momentum
Growth
EPS 1Y (TTM)3.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue 1Y (TTM)0.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.41%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%
EBIT growth 1Y42.73%
EBIT growth 3Y20.69%
EBIT growth 5Y17.72%
EBIT Next Year45.49%
EBIT Next 3Y20.21%
EBIT Next 5YN/A
FCF growth 1Y13.74%
FCF growth 3Y1.15%
FCF growth 5Y12.49%
OCF growth 1Y13.37%
OCF growth 3Y2.04%
OCF growth 5Y9.96%